David Mulham Mulham insider trades: Usana Health Sciences (USNA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | USNA | ↓ Sell | 873 | $21.00 | $18K | Direct | Dec 11, 2025 (1d) |
| Jul 30, 2025 | USNA | ↓ Sell | 3,515 | $30.26 | $106K | Direct | Jul 31, 2025 (1d) |
| Mar 10, 2025 | USNA | ↓ Sell | 3,234 | $32.98 | $107K | Direct | Mar 11, 2025 (1d) |
| Feb 29, 2024 | USNA | ↓ Sell | 4,311 | $47.76 | $206K | Direct | Mar 4, 2024 (4d) |
| Aug 15, 2023 | USNA | ↓ Sell | 2,159 | $65.34 | $141K | Direct | Aug 16, 2023 (1d) |
| Aug 11, 2023 | USNA | ↓ Sell | 1,080 | $66.28 | $72K | Direct | Aug 15, 2023 (4d) |
| Jul 31, 2023 | USNA | ↓ Sell | 3,354 | $65.00 | $218K | Direct | Aug 1, 2023 (1d) |
| Jun 15, 2023 | USNA | ↓ Sell | 1,557 | $61.00 | $95K | Direct | Jun 16, 2023 (1d) |
| Apr 28, 2023 | USNA | ↓ Sell | 1,138 | $67.40 | $77K | Direct | Apr 28, 2023 (0d) |
| Dec 7, 2021 | USNA | ↓ Sell | 873 | $101.50 | $89K | Direct | Dec 8, 2021 (1d) |
| Nov 15, 2021 | USNA | ↓ Sell | 569 | $102.00 | $58K | Direct | Nov 16, 2021 (1d) |
| Nov 11, 2021 | USNA | ↓ Sell | 1,111 | $100.74 | $112K | Direct | Nov 12, 2021 (1d) |
| Nov 4, 2021 | USNA | ↓ Sell | 1,398 | $101.77 | $142K | Direct | Nov 8, 2021 (4d) |
| Nov 3, 2021 | USNA | ↓ Sell | 1,277 | $99.63 | $127K | Direct | Nov 4, 2021 (1d) |
| Mar 1, 2021 | USNA | ↓ Sell | 2,783 | $97.87 | $272K | Direct | Mar 2, 2021 (1d) |
| Feb 18, 2021 | USNA | ↓ Sell | 3,145 | $91.00 | $286K | Direct | Feb 22, 2021 (4d) |
| Feb 10, 2020 | USNA | ↓ Sell | 3,798 | $81.00 | $308K | Direct | Feb 10, 2020 (0d) |
| May 16, 2018 | USNA | ↓ Sell | 14,733 | $113.03 | $1.7M | Direct | May 18, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other USNA insiders
Open-market trades in the last 12 months
About David Mulham Mulham's insider trades
David Mulham Mulham is Chief Sales Officer at Usana Health Sciences (USNA). Since May 16, 2018, David has reported no open-market purchases and 18 sales worth $4.1M on SEC Form 4. In the last 12 months: 1 sale ($18K).
Their filings also include option exercises (20 filings), grants and awards (10 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every USNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.